280 related articles for article (PubMed ID: 33275150)
1. Estimated Cost-effectiveness of Newborn Screening for Congenital Cytomegalovirus Infection in China Using a Markov Model.
Chen K; Zhong Y; Gu Y; Sharma R; Li M; Zhou J; Wu Y; Gao Y; Qin G
JAMA Netw Open; 2020 Dec; 3(12):e2023949. PubMed ID: 33275150
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of Universal and Targeted Newborn Screening for Congenital Cytomegalovirus Infection.
Gantt S; Dionne F; Kozak FK; Goshen O; Goldfarb DM; Park AH; Boppana SB; Fowler K
JAMA Pediatr; 2016 Dec; 170(12):1173-1180. PubMed ID: 27723885
[TBL] [Abstract][Full Text] [Related]
3. Contribution of Congenital Cytomegalovirus Infection to Permanent Hearing Loss in a Highly Seropositive Population: The Brazilian Cytomegalovirus Hearing and Maternal Secondary Infection Study.
Yamamoto AY; Anastasio ART; Massuda ET; Isaac ML; Manfredi AKS; Cavalcante JMS; Carnevale-Silva A; Fowler KB; Boppana SB; Britt WJ; Mussi-Pinhata MM
Clin Infect Dis; 2020 Mar; 70(7):1379-1384. PubMed ID: 31102409
[TBL] [Abstract][Full Text] [Related]
4. Results of a Targeted Screening Program for Congenital Cytomegalovirus Infection in Infants Who Fail Newborn Hearing Screening.
Vancor E; Shapiro ED; Loyal J
J Pediatric Infect Dis Soc; 2019 Mar; 8(1):55-59. PubMed ID: 29373759
[TBL] [Abstract][Full Text] [Related]
5. Universal newborn screening for congenital cytomegalovirus infection: feasibility and relevance in a French type-III maternity cohort.
Letamendia-Richard E; Périllaud-Dubois C; de La Guillonnière L; Thouard I; Cordier AG; Roque-Afonso AM; de Luca D; Benachi A; Vauloup-Fellous C
BJOG; 2022 Jan; 129(2):291-299. PubMed ID: 34726316
[TBL] [Abstract][Full Text] [Related]
6. The economics of screening infants at risk of hearing impairment: an international analysis.
Burke MJ; Shenton RC; Taylor MJ
Int J Pediatr Otorhinolaryngol; 2012 Feb; 76(2):212-8. PubMed ID: 22129917
[TBL] [Abstract][Full Text] [Related]
7. The cost-effectiveness of targeted screening for congenital cytomegalovirus in newborns compared to clinical diagnosis in the US.
Phillips VL; Xu J; Park A; Gantt S; Dedhia K
Int J Pediatr Otorhinolaryngol; 2023 Mar; 166():111450. PubMed ID: 36773448
[TBL] [Abstract][Full Text] [Related]
8. A Markov Analysis of Screening for Late-Onset Cytomegalovirus Disease in Cytomegalovirus High-Risk Kidney Transplant Recipients.
Puttarajappa CM; Hariharan S; Smith KJ
Clin J Am Soc Nephrol; 2018 Feb; 13(2):290-298. PubMed ID: 29025787
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of neonatal hearing screening program in China: should universal screening be prioritized?
Huang LH; Zhang L; Tobe RY; Qi FH; Sun L; Teng Y; Ke QL; Mai F; Zhang XF; Zhang M; Yang RL; Tu L; Li HH; Gu YQ; Xu SN; Yue XY; Li XD; Qi BE; Cheng XH; Tang W; Xu LZ; Han DM
BMC Health Serv Res; 2012 Apr; 12():97. PubMed ID: 22510223
[TBL] [Abstract][Full Text] [Related]
10. Newborn hearing screening: the great omission.
Mehl AL; Thomson V
Pediatrics; 1998 Jan; 101(1):E4. PubMed ID: 9417168
[TBL] [Abstract][Full Text] [Related]
11. Neonates with congenital Cytomegalovirus and hearing loss identified via the universal newborn hearing screening program.
Rawlinson WD; Palasanthiran P; Hall B; Al Yazidi L; Cannon MJ; Cottier C; van Zuylen WJ; Wilkinson M
J Clin Virol; 2018 May; 102():110-115. PubMed ID: 29571077
[TBL] [Abstract][Full Text] [Related]
12. Economic evaluation of long-term impacts of universal newborn hearing screening.
Chiou ST; Lung HL; Chen LS; Yen AM; Fann JC; Chiu SY; Chen HH
Int J Audiol; 2017 Jan; 56(1):46-52. PubMed ID: 27598544
[TBL] [Abstract][Full Text] [Related]
13. Cost-benefit analysis of targeted hearing directed early testing for congenital cytomegalovirus infection.
Bergevin A; Zick CD; McVicar SB; Park AH
Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2090-3. PubMed ID: 26432541
[TBL] [Abstract][Full Text] [Related]
14. First estimates of the potential cost and cost saving of protecting childhood hearing from damage caused by congenital CMV infection.
Williams EJ; Gray J; Luck S; Atkinson C; Embleton ND; Kadambari S; Davis A; Griffiths P; Sharland M; Berrington JE; Clark JE
Arch Dis Child Fetal Neonatal Ed; 2015 Nov; 100(6):F501-6. PubMed ID: 26122458
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of congenital CMV infection via DBS samples testing and neonatal hearing screening: an observational study in Italy.
Pellegrinelli L; Galli C; Primache V; Alde' M; Fagnani E; Di Berardino F; Zanetti D; Pariani E; Ambrosetti U; Binda S
BMC Infect Dis; 2019 Jul; 19(1):652. PubMed ID: 31331274
[TBL] [Abstract][Full Text] [Related]
16. The cost-effectiveness of maternal and neonatal screening for congenital cytomegalovirus infection in Japan.
Aoki H; Bitnun A; Kitano T
J Med Virol; 2023 Jan; 95(1):e28391. PubMed ID: 36484373
[TBL] [Abstract][Full Text] [Related]
17. Projected cost-effectiveness of statewide universal newborn hearing screening.
Keren R; Helfand M; Homer C; McPhillips H; Lieu TA
Pediatrics; 2002 Nov; 110(5):855-64. PubMed ID: 12415021
[TBL] [Abstract][Full Text] [Related]
18. Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis.
Venditti LN; Venditti CP; Berry GT; Kaplan PB; Kaye EM; Glick H; Stanley CA
Pediatrics; 2003 Nov; 112(5):1005-15. PubMed ID: 14595039
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of a national neonatal hearing screening program in China: conditions for the scale-up.
Tobe RG; Mori R; Huang L; Xu L; Han D; Shibuya K
PLoS One; 2013; 8(1):e51990. PubMed ID: 23341887
[TBL] [Abstract][Full Text] [Related]
20. A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID).
Chan K; Davis J; Pai SY; Bonilla FA; Puck JM; Apkon M
Mol Genet Metab; 2011 Nov; 104(3):383-9. PubMed ID: 21810544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
